Hepatorenal syndrome precipitated by infective endocarditis

Br J Hosp Med (Lond). 2011 Sep;72(9):532-3. doi: 10.12968/hmed.2011.72.9.532.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / adverse effects
  • Contraindications
  • Daptomycin / administration & dosage
  • Daptomycin / adverse effects
  • Disease Progression
  • Drug Substitution
  • Echocardiography, Transesophageal
  • Endocarditis* / complications
  • Endocarditis* / diagnosis
  • Endocarditis* / drug therapy
  • Endocarditis* / microbiology
  • Fatal Outcome
  • Fluid Therapy
  • Hepatic Encephalopathy / etiology
  • Hepatic Encephalopathy / physiopathology
  • Hepatic Encephalopathy / therapy
  • Hepatorenal Syndrome* / etiology
  • Hepatorenal Syndrome* / physiopathology
  • Hepatorenal Syndrome* / therapy
  • Humans
  • Kidney Function Tests
  • Liver Transplantation
  • Male
  • Microbial Sensitivity Tests
  • Rifampin / administration & dosage
  • Rifampin / adverse effects
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcus lugdunensis / drug effects
  • Staphylococcus lugdunensis / isolation & purification*
  • Staphylococcus lugdunensis / pathogenicity
  • Vancomycin / administration & dosage
  • Vancomycin / adverse effects

Substances

  • Anti-Bacterial Agents
  • Vancomycin
  • Daptomycin
  • Rifampin